Skip to main content
Clinical Trials/IRCT20100427003813N7
IRCT20100427003813N7
Completed
Phase 3

Clinical and radiographic evaluation of applying 1.2% Atorvastatin gel with plasma rich in growth factor (PRGF) for treatment of class II furcation involvement

Babol University of Medical Sciences0 sites24 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
furcation grade 2 involvement of lower jaw molars.
Sponsor
Babol University of Medical Sciences
Enrollment
24
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with moderate to severe chronic periodontitis with severe grade II fractures on the buccal or lingual side of the first or second mandibular molars
  • The horizontal probing depth of the probes in the affected areas is greater than or equal to 3mm

Exclusion Criteria

  • Systemic disease
  • The need for prophylactic antibiotics to prevent bacterial endocarditis
  • Use of intermittent drugs with periodontal improvement
  • presence of contraindication for periodontal surgery
  • dental anatomical complications such as accessory canal concavity CEP, bifurcation ridge
  • Tooth mobility more than Grade II
  • The presence of decay and filling in the area of ??forcation
  • There is evidence of periapical pathology in the clinical or radiographic view of the tooth
  • Possibility of unaccompanied consent after initial periodontal treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials